Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-09 Purchase | 2023-05-10 4:12 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 20,000 | $1.2596 | $25,192 | 312,816 (Direct) | View |
| 2023-03-17 Sale | 2023-03-20 4:16 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 6,999 | $1.783 | $12,479 | 292,816 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 4:21 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 5,441 | $5.056 | $27,510 | 194,815 (Direct) | View |
| 2022-09-19 Sale | 2022-09-20 4:08 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 3,394 | $6.938 | $23,548 | 198,257 (Direct) | View |
| 2022-08-05 Purchase | 2022-08-08 4:14 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 8,606 | $5.8041 | $49,950 | 198,771 (Direct) | View |
| 2022-06-17 Sale | 2022-06-21 4:07 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 4,552 | $4.991 | $22,719 | 190,165 (Direct) | View |
| 2022-03-17 Sale | 2022-03-18 4:29 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 571 | $4.58 | $2,615 | 194,717 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Option Award | 2024-03-15 4:30 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 1,096,000 | $0 | 1,408,816 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:21 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 550,000 | $0 | 744,815 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:48 pm | N/A 2032-06-07 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 91,000 | $0 | 91,000 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-16 5:08 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 116,000 | $0 | 687,288 (Direct) | View |
| 2021-10-29 Option Award | 2021-11-01 4:48 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 26,700 | $0 | 114,550 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-18 5:06 pm | N/A 2031-05-17 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 140,000 | $0 | 170,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-01-29 5:00 pm | N/A 2031-01-28 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. Chief Operating Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2020-06-18 Option Award | 2020-07-02 4:30 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer | 488 | $8.36 | 0 (Direct) | View |
| 2020-07-02 Disposition | 2020-07-02 4:30 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer | 263,541 | $0 | 0 (Direct) | View |
| 2020-07-02 Disposition | 2020-07-02 4:30 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer | 5,563 | $18 | 0 (Direct) | View |
| 2020-07-02 Disposition | 2020-07-02 4:30 pm | N/A 2030-01-30 | PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer | 65,000 | $5.21 | 0 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-03 6:54 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer | 4,327 | $9.68 | 37,991 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-26 8:35 pm | N/A 2023-02-24 | PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer | 73,125 | $0 | 73,125 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 6:57 pm | N/A 2030-01-30 | PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer | 81,250 | $0 | 106,523 (Direct) | View |